352 related articles for article (PubMed ID: 18826501)
1. The role of caveolin-1 in cardiovascular regulation.
Rahman A; Swärd K
Acta Physiol (Oxf); 2009 Feb; 195(2):231-45. PubMed ID: 18826501
[TBL] [Abstract][Full Text] [Related]
2. Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease.
Xu Y; Buikema H; van Gilst WH; Henning RH
Eur J Pharmacol; 2008 May; 585(2-3):256-60. PubMed ID: 18423600
[TBL] [Abstract][Full Text] [Related]
3. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.
Rath G; Dessy C; Feron O
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():105-9. PubMed ID: 20083858
[TBL] [Abstract][Full Text] [Related]
4. Caveolin, caveolae, and endothelial cell function.
Frank PG; Woodman SE; Park DS; Lisanti MP
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1161-8. PubMed ID: 12689915
[TBL] [Abstract][Full Text] [Related]
5. The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis.
Sbaa E; Frérart F; Feron O
Trends Cardiovasc Med; 2005 Jul; 15(5):157-62. PubMed ID: 16165011
[TBL] [Abstract][Full Text] [Related]
6. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.
Drab M; Verkade P; Elger M; Kasper M; Lohn M; Lauterbach B; Menne J; Lindschau C; Mende F; Luft FC; Schedl A; Haller H; Kurzchalia TV
Science; 2001 Sep; 293(5539):2449-52. PubMed ID: 11498544
[TBL] [Abstract][Full Text] [Related]
7. Caveolae and caveolins in the cardiovascular system.
Gratton JP; Bernatchez P; Sessa WC
Circ Res; 2004 Jun; 94(11):1408-17. PubMed ID: 15192036
[TBL] [Abstract][Full Text] [Related]
8. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
[TBL] [Abstract][Full Text] [Related]
9. Cavin proteins: New players in the caveolae field.
Briand N; Dugail I; Le Lay S
Biochimie; 2011 Jan; 93(1):71-7. PubMed ID: 20363285
[TBL] [Abstract][Full Text] [Related]
10. Caveolae: a once-elusive structure gets some respect.
Marx J
Science; 2001 Nov; 294(5548):1862-5. PubMed ID: 11729300
[No Abstract] [Full Text] [Related]
11. Caveolae, caveolin, and cavins: potential targets for the treatment of cardiac disease.
Das M; Das DK
Ann Med; 2012 Sep; 44(6):530-41. PubMed ID: 21651441
[TBL] [Abstract][Full Text] [Related]
12. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
Hnasko R; Lisanti MP
Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453
[TBL] [Abstract][Full Text] [Related]
13. Caveolae and caveolin in transmembrane signaling: Implications for human disease.
Schwencke C; Braun-Dullaeus RC; Wunderlich C; Strasser RH
Cardiovasc Res; 2006 Apr; 70(1):42-9. PubMed ID: 16412403
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo.
Pelat M; Dessy C; Massion P; Desager JP; Feron O; Balligand JL
Circulation; 2003 May; 107(19):2480-6. PubMed ID: 12719275
[TBL] [Abstract][Full Text] [Related]
15. Vascular caveolin deficiency supports the angiogenic effects of nitrite, a major end product of nitric oxide metabolism in tumors.
Frérart F; Lobysheva I; Gallez B; Dessy C; Feron O
Mol Cancer Res; 2009 Jul; 7(7):1056-63. PubMed ID: 19567781
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae.
Santibanez JF; Blanco FJ; Garrido-Martin EM; Sanz-Rodriguez F; del Pozo MA; Bernabeu C
Cardiovasc Res; 2008 Mar; 77(4):791-9. PubMed ID: 18065769
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae.
Li Q; Zhang Q; Wang M; Liu F; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
Arch Biochem Biophys; 2007 Oct; 466(2):250-9. PubMed ID: 17662956
[TBL] [Abstract][Full Text] [Related]
18. Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation: Ca2+ signals and gap junction function are regulated by caveolin in endothelial cells.
Saliez J; Bouzin C; Rath G; Ghisdal P; Desjardins F; Rezzani R; Rodella LF; Vriens J; Nilius B; Feron O; Balligand JL; Dessy C
Circulation; 2008 Feb; 117(8):1065-74. PubMed ID: 18268148
[TBL] [Abstract][Full Text] [Related]
19. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase.
Li Q; Zhang Q; Wang M; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
Biochimie; 2007 Jan; 89(1):169-77. PubMed ID: 17125900
[TBL] [Abstract][Full Text] [Related]
20. Caveolins and the regulation of endothelial nitric oxide synthase in the heart.
Feron O; Balligand JL
Cardiovasc Res; 2006 Mar; 69(4):788-97. PubMed ID: 16483868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
